חובות לטווח קצר של החברה: Allurion (ALUR)

Allurion Technologies generates moderately cyclical earnings from the fight against obesity, while the automation of capsule assembly minimizes personnel costs. Short-term debt on the GURU.Markets system chart demonstrates the financial leverage, where the value of 0.00 reflects this status. The rapid growth of the global non-surgical weight loss market facilitates the active expansion of the company's international distribution network.

This indicator measures the total volume of liabilities with a maturity of up to one year, reflecting the current liquidity and the company's dependence on prompt refinancing. The dynamics of financial liabilities with a maturity of up to 12 months demonstrate how Allurion Technologies (ALUR) finances the automation of medical capsule assembly lines, where an increase in borrowings may indicate investments in robotics to optimize staffing and scale production.